N-tert-butoxycarbonyl-L-tryptophan-L-glutamate dimethylester | 1105050-03-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N-tert-butoxycarbonyl-L-tryptophan-L-glutamate dimethylester
• 英文别名: Boc-Trp-Glu(OMe)-OMe；dimethyl (2S)-2-[[(2S)-3-(1H-indol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]pentanedioate
• CAS: 1105050-03-0
• 化学式: C₂₃H₃₁N₃O₇
• 分子量: 461.515
• InChiKey: AKZSEPMFWPMELM-ROUUACIJSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  33
• 可旋转键数：
  13
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.48
• 拓扑面积：
  136
• 氢给体数：
  3
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  N-tert-butoxycarbonyl-L-tryptophan-L-glutamate dimethylester 在 三异丙基硅烷 、 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 反应 12.0h， 以90%的产率得到L-tryptophan-L-glutamate dimethylester
  参考文献：
  名称：

  Tryptophan-containing dipeptide derivatives as potent PPARγ antagonists: Design, synthesis, biological evaluation, and molecular modeling

  摘要：

  The discovery of peroxisome proliferator-activated receptor gamma (PPAR gamma) antagonists (also termed "selective PPAR gamma modulators, SPPAR gamma M") is now of a great interest in the treatment of diabetes and obesity. The structure of compound la (G3335, Fig. 1), a novel class of PPAR gamma antagonist, is entirely different from that of other reported PPAR gamma antagonists. A series of 35 novel analogues (1b-1, 9a-d, 13a-t) were designed, synthesized and evaluated against the agonistic effects exerted by rosiglitazone. These results indicated that most functional groups of la were conserved, and six new compounds (1b, 1c, and 9a-d) exhibited strong PPAR gamma antagonistic activities (IC50 values of 5.2-25.8 mu M) against 10 mu M rosiglitazone in the promotion of the PPAR gamma-LBD-CBP (ligand-binding domain and cAMP-response-element binding protein) interaction as investigated by yeast two-hybrid technology based assay. Molecular modeling studies for compounds 1a-d, 1h, 9c-d, and 13a were also presented. (C) 2008 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2008.01.032
• 作为产物：
  描述：

  N-叔丁氧羰基-L-色氨酸 、 L-谷氨酸二甲酯盐酸盐 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 三乙胺 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 以92%的产率得到N-tert-butoxycarbonyl-L-tryptophan-L-glutamate dimethylester
  参考文献：
  名称：

  Tryptophan-containing dipeptide derivatives as potent PPARγ antagonists: Design, synthesis, biological evaluation, and molecular modeling

  摘要：

  The discovery of peroxisome proliferator-activated receptor gamma (PPAR gamma) antagonists (also termed "selective PPAR gamma modulators, SPPAR gamma M") is now of a great interest in the treatment of diabetes and obesity. The structure of compound la (G3335, Fig. 1), a novel class of PPAR gamma antagonist, is entirely different from that of other reported PPAR gamma antagonists. A series of 35 novel analogues (1b-1, 9a-d, 13a-t) were designed, synthesized and evaluated against the agonistic effects exerted by rosiglitazone. These results indicated that most functional groups of la were conserved, and six new compounds (1b, 1c, and 9a-d) exhibited strong PPAR gamma antagonistic activities (IC50 values of 5.2-25.8 mu M) against 10 mu M rosiglitazone in the promotion of the PPAR gamma-LBD-CBP (ligand-binding domain and cAMP-response-element binding protein) interaction as investigated by yeast two-hybrid technology based assay. Molecular modeling studies for compounds 1a-d, 1h, 9c-d, and 13a were also presented. (C) 2008 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2008.01.032

文献信息

• Data Science-Driven Analysis of Substrate-Permissive Diketopiperazine Reverse Prenyltransferase NotF: Applications in Protein Engineering and Cascade Biocatalytic Synthesis of (−)-Eurotiumin A
  作者：Samantha P. Kelly、Vikram V. Shende、Autumn R. Flynn、Qingyun Dan、Ying Ye、Janet L. Smith、Sachiko Tsukamoto、Matthew S. Sigman、David H. Sherman

  DOI：10.1021/jacs.2c06631

  日期：2022.10.26

  functionalization prevalent in the biosynthesis of a diverse array of biologically active bacterial, fungal, plant, and metazoan diketopiperazine (DKP) alkaloids. Toward the development of a unified strategy for biocatalytic construction of prenylated DKP indole alkaloids, we sought to identify and characterize a substrate-permissive C2 reverse prenyltransferase (PT). As the first tailoring event within the biosynthesis

  异戊二烯转移是一种早期碳氢键 (C–H) 功能化，普遍存在于多种具有生物活性的细菌、真菌、植物和后生动物二酮哌嗪 (DKP) 生物碱的生物合成中。为了开发异戊二烯化 DKP 吲哚生物碱生物催化构建的统一策略，我们试图鉴定和表征底物允许的 C2 反向异戊二烯基转移酶 (PT)。作为细胞毒性诺托酰胺代谢物生物合成中的第一个剪裁事件，PT NotF 催化短维胺 F 的 C2 反向异戊烯转移。解析 NotF 的晶体结构（与天然底物和异戊烯供体模拟物二甲基烯丙基 S-硫代二磷酸 (DMSPP) 形成复合物）揭示了一个大的，暴露于溶剂的活性位点，提示 NotF 可能具有非常广泛的底物范围。为了评估 NotF 的底物选择性，我们合成了一组 30 种空间和电子分化的色氨酸 DKP，其中大部分在合成有用的转化（2 至 >99%）中被 NotF 选择性异戊二烯化。该底物库的定量表示和描述性统计模型的开发提供了对
• Tryptophan-containing dipeptide derivatives as potent PPARγ antagonists: Design, synthesis, biological evaluation, and molecular modeling
  作者：Guanghui Deng、Zhiguo Liu、Fei Ye、Xiaomin Luo、Weiliang Zhu、Xu Shen、Hong Liu、Hualiang Jiang

  DOI：10.1016/j.ejmech.2008.01.032

  日期：2008.12

  The discovery of peroxisome proliferator-activated receptor gamma (PPAR gamma) antagonists (also termed "selective PPAR gamma modulators, SPPAR gamma M") is now of a great interest in the treatment of diabetes and obesity. The structure of compound la (G3335, Fig. 1), a novel class of PPAR gamma antagonist, is entirely different from that of other reported PPAR gamma antagonists. A series of 35 novel analogues (1b-1, 9a-d, 13a-t) were designed, synthesized and evaluated against the agonistic effects exerted by rosiglitazone. These results indicated that most functional groups of la were conserved, and six new compounds (1b, 1c, and 9a-d) exhibited strong PPAR gamma antagonistic activities (IC50 values of 5.2-25.8 mu M) against 10 mu M rosiglitazone in the promotion of the PPAR gamma-LBD-CBP (ligand-binding domain and cAMP-response-element binding protein) interaction as investigated by yeast two-hybrid technology based assay. Molecular modeling studies for compounds 1a-d, 1h, 9c-d, and 13a were also presented. (C) 2008 Elsevier Masson SAS. All rights reserved.